GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MaxCyte Inc (STU:MYE0) » Definitions » 12-1 Month Momentum %

MaxCyte (STU:MYE0) 12-1 Month Momentum % : 33.33% (As of Oct. 31, 2024)


View and export this data going back to 2021. Start your Free Trial

What is MaxCyte 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-10-31), MaxCyte's 12-1 Month Momentum % is 33.33%.

The industry rank for MaxCyte's 12-1 Month Momentum % or its related term are showing as below:

STU:MYE0's 12-1 Month Momentum % is ranked better than
76.33% of 849 companies
in the Medical Devices & Instruments industry
Industry Median: -6.05 vs STU:MYE0: 33.33

Competitive Comparison of MaxCyte's 12-1 Month Momentum %

For the Medical Devices subindustry, MaxCyte's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MaxCyte's 12-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MaxCyte's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where MaxCyte's 12-1 Month Momentum % falls into.



MaxCyte  (STU:MYE0) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MaxCyte  (STU:MYE0) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


MaxCyte 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of MaxCyte's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


MaxCyte Business Description

Traded in Other Exchanges
Address
9713 Key West Avenue, Suite 400, Rockville, MD, USA, 20850
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.

MaxCyte Headlines

No Headlines